After signing up, you'll start to receive regular news updates from us.
Illumina to Supply Natera with Sequencing Instruments and Consumables for NIPT
Complete the form below to unlock access to ALL audio articles.
Illumina, Inc. and Natera, Inc. have announced that they have entered into a three-year agreement whereby Illumina will supply Natera with the HiSeq® 2500 sequencing system and associated consumables for performing the non-invasive prenatal test (NIPT) Panorama™.
"We are pleased to be selected again as Natera's next-generation sequencing system provider, to support the growth of its Panorama™ test," said Nick Naclerio, Senior Vice President of Corporate and Venture Development at Illumina.
Naclerio continued, "Illumina's goal is to enable the rapid growth of NIPT and the broader reproductive health market with technology, products, and ultimately FDA-approved in vitro diagnostic systems."
Added Matthew Rabinowitz, Ph.D., Chief Executive Officer of Natera, "We are pleased to continue working with Illumina and its next-generation sequencing technology. This deal enables a major expansion of Natera's laboratory capacity to support the fast-growing demand for our Panorama™ test."
